Identify 2 drugs that reduce mortality between patients with COVID

Experts in United Kingdom identify drugs capable of reducing the number of deaths between patients in covid-19 patients by one quarter.

Treatment of anti-inflammatory drugs –tocilizumab y sarilumab– administered by goteo, who salvan a life for each 12 people receiving the treatment, according to the investigators he led a test in the intensive care units of the National Health Service of the United Kingdom (NHS, by its seals in English).

The experts say that the summitists are available everywhere in the United Kingdom, because they can be used immediately to save hundreds of lives.

There are more than 30,000 patients with covid-19 in the hospitals of the United Kingdom, a 39% more than in April.

Además de salvar más vidas, the treatments accelerate the recovery of the sick and reduces approximately once a week the patients in critical condition should not be in intensive care.

Both appear to work equally well and its beneficial effect is summed up as being stored with a steroid drug called a dexamethasone.

Although the drugs are not affordable – they cost between US $ 1,000 and US $ 1,350 per patient – experts say that the use of drugs is clear and clear that its price is less than the cost per day of an intensive care bed, de alrededor de US $ 2,700.

“For every 12 patients who treat themselves with these medications, it will save a life. It’s a great effect, ”said Professor Anthony Gordon, investigating officer at the Imperial College de London.

According to the REMAP-CAP study carried out in six different countries, including the United Kingdom, with around 800 intensive care patients:

• Cases 36% of patients with covid-19 of intensive care that receive attention stand murieron
• New medicines reduce this number by one quarter, to 27%, when administered within 24 hours of intensive care patients in intensive care

“The fact that there is another drug that can help reduce the mortality of patients with covid-19 is a very welcome news and other positive advances in the continuous fight against the virus,” said Professor Stephen Powis, National Medical Director. of the NHS.

The Secretary of Health and Social Attention of the United Kingdom, Matt Hancock, also celebrated the hall. “The results of this high historical advance in the search for a solution to this pandemic and, while aggregating into the arsenal of vacancies and treatments that are being implemented, will add an important dimension to the spread of this virus,” he said.

Pharmacies reduce inflammation, which can accelerate in patients with covid-19 and cause death in the pulses and other organs.

The experts are advising the doctors who administering to any patient with coronavirus whose condition is deteriorating, before receiving dexamethasone, and need intensive care.

The tocilizumab and the sarilumab are aggregated by the government in the list of products with which exportation is restricted, as the companies to buy medicines destined for patients from the United Kingdom and sell at a higher price elsewhere in the country.

The results of this investigation have not yet been reviewed by other experts and have been published in a medical review.

Now you can receive notifications from BBC News Mundo. Download our app and activate it to lose our best content.